Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Galvin

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The Journal of Prevention of Alzheimer'S Disease|May 29, 2020
Editorial: Screening for Mild Cognitive Impairment: There Is the Will but Is There a Way?J E Galvin
Veterinary Immunology and Immunopathology|October 1, 1994
Bacterial immunogens and protective immunity in swineM J Wannemuehler, J E Galvin
Journal of Medical Microbiology|March 25, 1998
Morphologic and temporal characterisation of lesions in an enhanced murine model of Serpulina hyodysenteriae infectionD L Hutto, J E Galvin, M J Wannemuehler
Archives of Neurology|February 15, 2001
Synucleinopathies: clinical and pathological implicationsJ E Galvin, V M Lee, J Q Trojanowski
The Journal of Clinical Investigation|July 21, 2000
Cytotoxic mAb from rheumatic carditis recognizes heart valves and lamininJ E Galvin, M E Hemric, K Ward, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 1999
Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synucleinJ E Galvin, K Uryu, V M Lee, et al.
Molecular Immunology|April 3, 2001
Molecular analysis of cross-reactive anti-myosin/anti-streptococcal mouse monoclonal antibodiesN M Mertens, J E Galvin, E E Adderson, et al.
Experimental Neurology|March 22, 2001
Differential expression and distribution of alpha-, beta-, and gamma-synuclein in the developing human substantia nigraJ E Galvin, T M Schuck, V M Lee, et al.
Biologicals : Journal of the International Association of Biological Standardization|August 3, 2001
Pasteurella multocida toxin type D serological assay as an alternative to the toxin neutralisation lethality test in miceD L Finco-Kent, J E Galvin, B T Suiter, et al.
International Journal of Clinical Practice|February 17, 2015
Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's diseaseG Alva, J L Cummings, J E Galvin, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Journal of Prevention of Alzheimer'S Disease|May 29, 2020
Editorial: Screening for Mild Cognitive Impairment: There Is the Will but Is There a Way?J E Galvin
Veterinary Immunology and Immunopathology|October 1, 1994
Bacterial immunogens and protective immunity in swineM J Wannemuehler, J E Galvin
Journal of Medical Microbiology|March 25, 1998
Morphologic and temporal characterisation of lesions in an enhanced murine model of Serpulina hyodysenteriae infectionD L Hutto, J E Galvin, M J Wannemuehler
Archives of Neurology|February 15, 2001
Synucleinopathies: clinical and pathological implicationsJ E Galvin, V M Lee, J Q Trojanowski
The Journal of Clinical Investigation|July 21, 2000
Cytotoxic mAb from rheumatic carditis recognizes heart valves and lamininJ E Galvin, M E Hemric, K Ward, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 1999
Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synucleinJ E Galvin, K Uryu, V M Lee, et al.
Molecular Immunology|April 3, 2001
Molecular analysis of cross-reactive anti-myosin/anti-streptococcal mouse monoclonal antibodiesN M Mertens, J E Galvin, E E Adderson, et al.
Experimental Neurology|March 22, 2001
Differential expression and distribution of alpha-, beta-, and gamma-synuclein in the developing human substantia nigraJ E Galvin, T M Schuck, V M Lee, et al.
Biologicals : Journal of the International Association of Biological Standardization|August 3, 2001
Pasteurella multocida toxin type D serological assay as an alternative to the toxin neutralisation lethality test in miceD L Finco-Kent, J E Galvin, B T Suiter, et al.
International Journal of Clinical Practice|February 17, 2015
Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's diseaseG Alva, J L Cummings, J E Galvin, et al.
Pageof 3